Xeris Biopharma Holdings, Inc. XERS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.23M-79.8% | $11.08M+1,684% | $621K+132% | -$1.93M+79.1% | -$9.22M-80.3% | ||
| $337K+0.6% | $335K-0.9% | $338K+4.0% | $325K+3.2% | $315K+0.6% | ||
| $4.14M-21.5% | $5.27M-31.0% | $7.64M+52.6% | $5.01M+12.7% | $4.44M+23.6% | ||
| $9.87M-50.8% | $20.04M+8.7% | $18.43M+10,027% | $182K+102% | -$10.03M— | ||
| -$325K+2.4% | -$333K-369% | -$71K+74.6% | -$279K-2,046% | -$13K-100% | ||
| -$8.84M— | —— | $13.85M— | —— | -$3.14M-888% | ||
| $708K-96.4% | $19.44M-39.6% | $32.21M+3,712% | $845K+106% | -$13.18M-206% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xeris Biopharma Holdings, Inc. generate?
- Xeris Biopharma Holdings, Inc. (XERS) generated $48.5M in operating cash flow over the trailing twelve months.
- Where does Xeris Biopharma Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
